array:24 [
  "pii" => "S0300289617303071"
  "issn" => "03002896"
  "doi" => "10.1016/j.arbres.2017.09.008"
  "estado" => "S300"
  "fechaPublicacion" => "2018-04-01"
  "aid" => "1725"
  "copyright" => "SEPAR"
  "copyrightAnyo" => "2017"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "crp"
  "cita" => "Arch Bronconeumol. 2018;54:223-5"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2133
    "formatos" => array:3 [
      "EPUB" => 133
      "HTML" => 1476
      "PDF" => 524
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S157921291830034X"
      "issn" => "15792129"
      "doi" => "10.1016/j.arbr.2018.02.004"
      "estado" => "S300"
      "fechaPublicacion" => "2018-04-01"
      "aid" => "1725"
      "copyright" => "SEPAR"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "crp"
      "cita" => "Arch Bronconeumol. 2018;54:223-5"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:2 [
        "total" => 1238
        "formatos" => array:3 [
          "EPUB" => 167
          "HTML" => 709
          "PDF" => 362
        ]
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>"
        "titulo" => "Application for Authorization for Therapeutic Use of Beta-Adrenergic Agonists and Inhaled Corticosteroids in Athletes with Asthma"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "223"
            "paginaFinal" => "225"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "La solicitud de autorizaci&#243;n de uso terap&#233;utico para agonistas betaadren&#233;rgicos y corticoides inhalados en el deportista con asma"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Franchek Drobnic, Jes&#250;s Blanco-Alfaro"
            "autores" => array:2 [
              0 => array:2 [
                "nombre" => "Franchek"
                "apellidos" => "Drobnic"
              ]
              1 => array:2 [
                "nombre" => "Jes&#250;s"
                "apellidos" => "Blanco-Alfaro"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "S0300289617303071"
          "doi" => "10.1016/j.arbres.2017.09.008"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617303071?idApp=UINPBA00003Z"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157921291830034X?idApp=UINPBA00003Z"
      "url" => "/15792129/0000005400000004/v2_201804150412/S157921291830034X/v2_201804150412/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0300289617303083"
    "issn" => "03002896"
    "doi" => "10.1016/j.arbres.2017.09.009"
    "estado" => "S300"
    "fechaPublicacion" => "2018-04-01"
    "aid" => "1726"
    "copyright" => "SEPAR"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Arch Bronconeumol. 2018;54:225-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3220
      "formatos" => array:3 [
        "EPUB" => 124
        "HTML" => 2352
        "PDF" => 744
      ]
    ]
    "es" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Carta cient&#237;fica</span>"
      "titulo" => "Micobacteriosis pulmonar en un paciente en tratamiento cr&#243;nico con metotrexato"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "225"
          "paginaFinal" => "226"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Pulmonary Mycobacteriosis in a Patient Receiving Chronic Methotrexate Treatment"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 563
              "Ancho" => 1400
              "Tamanyo" => 165494
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A&#41; TC tor&#225;cica&#58; consolidaciones pulmonares en l&#243;bulo medio&#44; l&#237;ngula y ambos l&#243;bulos inferiores&#46; B&#41; Biopsia transbronquial basal derecha&#58; presencia de neumonitis granulomatosa no necrosante &#40;tinci&#243;n hematoxilina-eosina&#44;4<span class="elsevierStyleHsp" style=""></span>x&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Mar&#237;a Agustina Dal Mol&#237;n-Veglia, Francisca S&#225;nchez-Mart&#237;nez, Antonio Fernando Fern&#225;ndez-Alarza, Marisol Dom&#237;nguez-&#193;lvarez"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Mar&#237;a Agustina"
              "apellidos" => "Dal Mol&#237;n-Veglia"
            ]
            1 => array:2 [
              "nombre" => "Francisca"
              "apellidos" => "S&#225;nchez-Mart&#237;nez"
            ]
            2 => array:2 [
              "nombre" => "Antonio Fernando"
              "apellidos" => "Fern&#225;ndez-Alarza"
            ]
            3 => array:2 [
              "nombre" => "Marisol"
              "apellidos" => "Dom&#237;nguez-&#193;lvarez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1579212918300351"
        "doi" => "10.1016/j.arbr.2018.02.005"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212918300351?idApp=UINPBA00003Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617303083?idApp=UINPBA00003Z"
    "url" => "/03002896/0000005400000004/v2_201804150418/S0300289617303083/v2_201804150418/es/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S030028961730306X"
    "issn" => "03002896"
    "doi" => "10.1016/j.arbres.2017.08.010"
    "estado" => "S300"
    "fechaPublicacion" => "2018-04-01"
    "aid" => "1724"
    "copyright" => "SEPAR"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Arch Bronconeumol. 2018;54:222-3"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2879
      "formatos" => array:3 [
        "EPUB" => 160
        "HTML" => 2144
        "PDF" => 575
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>"
      "titulo" => "Systemic Lupus Erythematosus Presenting as Acute Lupus Pneumonitis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "222"
          "paginaFinal" => "223"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Lupus eritematoso sist&#233;mico manifestado como neumonitis l&#250;pica aguda"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1179
              "Ancho" => 1250
              "Tamanyo" => 188470
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">66-Year-old woman with systemic lupus erythematosus presenting with acute lupus pneumonitis&#46; &#40;A&#41; Chest X-ray showing right pleural effusion &#40;asterisk&#41; and pulmonary consolidation in right upper lobe&#46; &#40;B&#41; On the chest X-ray three days later&#44; a right encapsulated pleural effusion &#40;asterisk&#41; was observed&#46; &#40;C&#41; Practical disappearance of encapsulated effusion in the thoracic study two months later&#44; with a thickening of the right costal pleura and a lateral costophrenic sinus&#46; &#40;D&#41; Axial section of the computed tomography study at 6 months&#44; at the level of the pulmonary bases with a mediastinum window was normal&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Biljana Lazovic, Mirjana Zlatkovic-Svenda, Damir Jasarovic, Dejan Stevanovic"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Biljana"
              "apellidos" => "Lazovic"
            ]
            1 => array:2 [
              "nombre" => "Mirjana"
              "apellidos" => "Zlatkovic-Svenda"
            ]
            2 => array:2 [
              "nombre" => "Damir"
              "apellidos" => "Jasarovic"
            ]
            3 => array:2 [
              "nombre" => "Dejan"
              "apellidos" => "Stevanovic"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1579212918300533"
        "doi" => "10.1016/j.arbr.2017.08.018"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212918300533?idApp=UINPBA00003Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S030028961730306X?idApp=UINPBA00003Z"
    "url" => "/03002896/0000005400000004/v2_201804150418/S030028961730306X/v2_201804150418/en/main.assets"
  ]
  "es" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Carta cient&#237;fica</span>"
    "titulo" => "La solicitud de autorizaci&#243;n de uso terap&#233;utico para agonistas betaadren&#233;rgicos y corticoides inhalados en el deportista con asma"
    "tieneTextoCompleto" => true
    "saludo" => "<span class="elsevierStyleItalic">Estimado Director&#58;</span>"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "223"
        "paginaFinal" => "225"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Franchek Drobnic, Jes&#250;s Blanco-Alfaro"
        "autores" => array:2 [
          0 => array:4 [
            "nombre" => "Franchek"
            "apellidos" => "Drobnic"
            "email" => array:1 [
              0 => "drobnic&#64;car&#46;edu"
            ]
            "referencia" => array:4 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              3 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Jes&#250;s"
            "apellidos" => "Blanco-Alfaro"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:4 [
          0 => array:3 [
            "entidad" => "Departamento de Investigaci&#243;n en Ciencias del deporte del CAR&#44; Sant Cugat del Vall&#233;s&#44; Barcelona&#44; Espa&#241;a"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Servicios M&#233;dicos FC&#44; Barcelona"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Unidad Medicina del Deporte&#44; Hospital San Juan de Dios&#44; Barcelona&#44; Espa&#241;a"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
          3 => array:3 [
            "entidad" => "Departamento de Control del Dopaje&#44; Agencia Espa&#241;ola de Protecci&#243;n de la Salud en el Deporte AEPSAD&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "d"
            "identificador" => "aff0020"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Application for Authorization for Therapeutic Use of Beta-Adrenergic Agonists and Inhaled Corticosteroids in Athletes with Asthma"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Desde que en 1972 Rick Demont perdiera su medalla de oro en Munich por tomar una medicaci&#243;n no permitida&#44; la legislaci&#243;n antidopaje en el &#225;mbito del asma y el deporte se ha ido adecuando cada temporada para ser m&#225;s concisa y facilitar la vida del deportista con asma y como no&#44; la del m&#233;dico que prescribe la medicaci&#243;n&#46; Desde enero del 2013 se puede tratar el asma sin grandes limitaciones y sin necesidad de elevar una solicitud a organismos deportivos oficiales<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">1&#44;2</span></a>&#46; Pero&#44; hay que leer la normativa&#44; porque la permisividad se fundamenta en una terapia adecuada&#46; En ese sentido&#44; el apartado S3 sobre la normativa reza lo siguiente<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">3</span></a>&#58; <span class="elsevierStyleItalic">&#171;Se proh&#237;ben todos los beta-2 agonistas selectivos y no selectivos&#44; incluidos todos sus is&#243;meros &#243;pticos&#46; Incluidos&#44; entre otros&#58; fenoterol&#59; formoterol&#59; higenamina&#59; indacaterol&#59; olodaterol&#59; procaterol&#59; reproterol&#59; salbutamol&#59; salmeterol&#59; terbatulina&#59; vilanterol&#46; Excepto&#58; salbutamol inhalado&#58; cantidad m&#225;xima 1&#46;600 mcg en 24 h&#44; sin superar los 800 mcg cada 12 h&#46; Formoterol inhalado&#58; dosis m&#225;xima administrada 54 mcg en 24 h&#46; Salmeterol inhalado&#58; cantidad m&#225;xima 200 mcg en 24 h&#46; Que se corresponde a unos rangos de dosis superiores a las terap&#233;uticas de los tres&#46; Se presumir&#225; que la presencia en la orina de una concentraci&#243;n de salbutamol superior a 1&#46;000 nanogramos por mililitro o de formoterol superior a 40 nanogramos por mililitro no corresponde a un uso terap&#233;utico intencionado de la sustancia y se considerar&#225; un resultado anal&#237;tico adverso &#40;AAF&#41;&#44; a menos que el deportista demuestre mediante un estudio farmacocin&#233;tico controlado que este resultado adverso fue consecuencia del uso de la dosis terap&#233;utica &#40;por inhalaci&#243;n&#41; que alcanzaba la dosis m&#225;xima indicada supra&#187;&#46;</span> Es decir&#44; se permite salbutamol&#44; salmeterol y&#47;o formoterol asociado o no a cualquiera de los corticoides inhalados del mercado farmac&#233;utico a dosis terap&#233;uticas&#46; En esos casos no hay que enviar ninguna solicitud&#44; solo dedicarse al paciente&#46; Si se considera que precisa un broncodilatador de los que no est&#225;n permitidos por razones terap&#233;uticas propias de la idiosincrasia personal&#44; de evoluci&#243;n con terapias previas&#44; adherencia&#44; sensaciones o comodidad de uso&#44; etc&#46; se deber&#225; justificar la raz&#243;n de esa decisi&#243;n y aportar la documentaci&#243;n que demuestre que el sujeto es asm&#225;tico y que padece una labilidad bronquial real&#44; mediante una solicitud de autorizaci&#243;n terap&#233;utica &#40;AUT&#41;&#46; En ella se deber&#225; demostrar primero&#44; mediante informes precisos y pruebas cl&#237;nicas avaladas la enfermedad que se padece<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">4</span></a>&#59; segundo&#44; que la sustancia prohibida o m&#233;todo en cuesti&#243;n es necesario para tratar un problema m&#233;dico agudo o cr&#243;nico de tal naturaleza que la salud experimentar&#237;a un deterioro significativo si no fuera tratado&#59; tercero&#44; que no existe una alternativa terap&#233;utica razonable al uso de la sustancia prohibida y cuarto&#44; que es muy improbable que el tratamiento pueda producir una mejora de su rendimiento superior a la que podr&#237;a preverse al regresar a su estado de salud normal<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">5</span></a>&#46; La raz&#243;n de que algunos agonistas beta2 no est&#233;n permitidos no es un capricho o una maniobra econ&#243;mica de grupos de presi&#243;n&#44; se basa en el cuarto punto de las condiciones para solicitar una AUT y es porque estas sustancias a dosis terap&#233;uticas s&#237; tratan el asma&#44; pero en concentraciones elevadas&#44; adem&#225;s&#44; ofrecen un efecto ergog&#233;nico diverso<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">6&#44;7</span></a> que es utilizado con fines anti&#233;ticos por algunos individuos&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">La eficiencia de nuestro trabajo como m&#233;dicos se traslada a la de todos aquellos a quien alcanza&#44; al paciente&#44; a su familia&#44; los organismos deportivos&#44; los compa&#241;eros que nos ayudan a hacer las pruebas complementarias&#44; o los que valoran las solicitudes&#46; Una AUT no es un tr&#225;mite&#46; No basta con rellenar un formulario de solicitud&#46; Es una solicitud oficial&#44; seria&#44; para permitir tomar una medicaci&#243;n y debe ser completa y bien argumentada&#46; En ella&#44; ser&#225; necesario adjuntar pruebas complementarias que afectan a diversos profesionales&#44; en las que los resultados no siempre son los deseados<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">8</span></a>&#44; hay justificar los puntos expuestos que condicionan la solicitud y cumplimentar un documento oficial&#46; En definitiva&#44; hay que dedicar calidad en el trabajo y tiempo&#46; Es tambi&#233;n perentorio matizar que una AUT no es un documento para presentar &#171;por si acaso&#187; y tramitarlo porque se ha o&#237;do que &#171;estas medicaciones pueden dar dopaje&#187;&#46; Las medicaciones para el asma y para otras patolog&#237;as o son dopaje o no lo son&#44; o pueden devenir un control de <span class="elsevierStyleItalic">resultado adverso</span> en unas condiciones determinadas&#46; Cualquier solicitud la eval&#250;a cada uno de los miembros de la Comisi&#243;n de Autorizaciones Terap&#233;uticas de la Agencia Espa&#241;ola Antidopaje y Protecci&#243;n de la Salud del Deportista &#40;CAUT&#41; y genera dedicaci&#243;n de diversas personas a la vez que ciertos tr&#225;mites administrativos&#46; La CAUT no juzga los tratamientos <span class="elsevierStyleItalic">per se</span>&#44; juzga si la solicitud de ese tratamiento&#44; que est&#225; refrendado por un m&#233;dico especialista&#44; cumple los requisitos adecuados para permitir al deportista utilizar una sustancia prohibida que&#44; si bien facilitar&#225; entrenar y competir en condiciones de salud similares a sus compa&#241;eros en una competici&#243;n limpia&#44; tambi&#233;n puede beneficiarle en su rendimiento<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">9</span></a>&#46; Este nivel comentado de calidad no siempre se observa&#46; Como se ve en la tabla adjunta &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#44; de un total de 465 solicitudes realizadas durante el a&#241;o 2015&#44; 131&#40;28&#44;2&#37;&#41; eran de agonistas beta&#44; y de estas 61&#40;46&#44;6&#37;&#41; no proced&#237;a hacerlas&#46; Por otra parte&#44; en una de cada cuatro de las 69 correspondientes a terbutalina&#44; se solicit&#243; la subsanaci&#243;n pidiendo un informe m&#225;s completo&#44; o razonando sobre todo los puntos 2&#46;&#176; y 3&#46;&#176; antes indicados&#46; Abundo en este aspecto pues el tercer punto es el que hay que justificar m&#225;s&#44; pues existe tratamiento alternativo a la misma&#44; y el cuarto es el que impide que algunos broncodilatadores no est&#233;n permitidos y precisen AUT<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">10&#44;11</span></a>&#46; Con respecto al total de las solicitudes de uso de corticoides en relaci&#243;n con el asma&#44; cerca del 100&#37; no son procedentes dado que son tratamientos y v&#237;as de administraci&#243;n permitidas&#46; En resumen&#44; de 202 solicitudes relacionadas con el tratamiento del asma formalizadas por neum&#243;logos&#44; alerg&#243;logos&#44; pediatras&#44; m&#233;dicos de familia&#44; m&#233;dicos generalistas y m&#233;dicos del deporte&#44; 132&#40;65&#37;&#41; no eran necesarias y 21&#40;10&#37;&#41; hubo que repetirlas&#46; Seguro que lo sabemos hacer mejor&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "multimedia" => array:1 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Se indican los porcentajes de las m&#225;s importantes&#46; Las relativas a betametasona y budesonida no son solo para el asma y pertenecen tambi&#233;n a terapias antiinflamatorias de otros sistemas&#46; De las correspondientes a asma no se deneg&#243; ninguna&#46;</p>"
          "tablatextoimagen" => array:2 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " colspan="6" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Autorizaciones terap&#233;uticas resueltas a&#241;o 2015 -n&#58; 465-</th></tr><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Beta2 agonistas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Solicitudes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">No procede&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Subsanaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Concedida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">No concedida o desestimada&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Formoterol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">23&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">23&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Salbutamol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">31&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">31&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Salmeterol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Terbutalina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">69 &#40;52&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">17 &#40;24&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">39 &#40;56&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">13 &#40;18&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Vilanterol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">131&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">61 &#40;46&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">17 &#40;13&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">40 &#40;30&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">13 &#40;9&#44;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1720587.png"
              ]
            ]
            1 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Corticoesteroides&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Solicitudes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">No procede&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Subsanaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Concedida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">No concedida o desestimada&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Prednisona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">36&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">31&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Budesonida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">27&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">24 &#40;88&#44;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Fluticasona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">27&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">26 &#40;96&#44;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Metilprednisolona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">23&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dexametasona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">23&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">21&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Betametasona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">15&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10 &#40;66&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Deflazacort&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">15&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">15&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Triamcinolona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Beclometasona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">7 &#40;87&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Mometasona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ciclesonida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Metilprednisona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Otros&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">192&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">77 &#40;40&#44;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">11 &#40;5&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">103 &#40;53&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">12 &#40;6&#44;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1720586.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Caracter&#237;sticas de las resoluciones de las autorizaciones terap&#233;uticas valoradas por la Comisi&#243;n de Autorizaciones Terap&#233;uticas de la AEPSAD durante el a&#241;o 2015</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:11 [
            0 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "La informaci&#243;n desinformada&#58; el asma en los deportistas de &#233;lite&#46; De Maim&#243;nides a los Juegos Ol&#237;mpicos"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "F&#46; Drobnic"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Bronconeumol&#46;"
                        "fecha" => "2001"
                        "volumen" => "37"
                        "paginaInicial" => "363"
                        "paginaFinal" => "365"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11674933"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "El deportista con asma y la nueva normativa antidopaje de 2010 Menos trabajo a cambio de una terapia limitada"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "F&#46; Drobnic"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.arbres.2009.11.006"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Bronconeumol&#46;"
                        "fecha" => "2010"
                        "volumen" => "46"
                        "paginaInicial" => "280"
                        "paginaFinal" => "281"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20092924"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Bolet&#237;n Oficial del Estado&#44; N&#250;m&#46; 6&#44; S&#225;bado 7 de enero de 2017&#46; Sec&#46; I&#46; pp&#46; 766-775&#46;"
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0120"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "&#91;consultado 16 Oct 2017&#93; &#46; Disponible en&#58; https&#58;&#47;&#47;www&#46;wada-ama&#46;org&#47;en&#47;resources&#47;therapeutic-use-exemption-tue&#47;medical-information-to-support-the-decisions-of-tuecs-asthma&#46;"
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0125"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "&#91;consultado 16 Oct 2017&#93;&#46; Disponible en&#58; http&#58;&#47;&#47;www&#46;aepsad&#46;gob&#46;es&#47;aepsad&#47;control-dopaje&#47;autorizaciones-de-uso-terapeutico&#46;html&#46;"
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Can asthma treatment in sports be doping&#63; The effect of the rapid onset&#44; long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "K&#46;H&#46; Carlsen"
                            1 => "E&#46; Hem"
                            2 => "T&#46; Stensrud"
                            3 => "T&#46; Held"
                            4 => "K&#46; Herland"
                            5 => "P&#46; Mowinckel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/rmed.2001.1105"
                      "Revista" => array:6 [
                        "tituloSerie" => "Respir Med&#46;"
                        "fecha" => "2001"
                        "volumen" => "95"
                        "paginaInicial" => "571"
                        "paginaFinal" => "576"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11453313"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "&#946;-Agonists and physical performance&#58; a systematic review and meta-analysis of randomized controlled trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "B&#46;M&#46; Pluim"
                            1 => "O&#46; de Hon"
                            2 => "J&#46;B&#46; Staal"
                            3 => "J&#46; Limpens"
                            4 => "H&#46; Kuipers"
                            5 => "S&#46;E&#46; Overbeek"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2165/11537540-000000000-00000"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sports Med&#46;"
                        "fecha" => "2011"
                        "volumen" => "41"
                        "paginaInicial" => "39"
                        "paginaFinal" => "57"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21142283"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Consideraciones sobre el informe de la prueba de broncoconstricci&#243;n en el deportistaJT Arch Med Deporte"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "F&#46; Drobnic"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "fecha" => "1997"
                        "volumen" => "58"
                        "paginaInicial" => "147"
                        "paginaFinal" => "148"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mechanisms underlying enhancements in muscle force and power output during maximal cycle ergometer exercise induced by chronic &#40;2-adrenergic stimulation in men"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Hostrup"
                            1 => "A&#46; Kalsen"
                            2 => "J&#46; Onslev"
                            3 => "S&#46; Jessen"
                            4 => "C&#46; Haase"
                            5 => "S&#46; Habib"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Appl Physiol &#40;1985&#41;&#46;"
                        "fecha" => "2015"
                        "volumen" => "119"
                        "paginaInicial" => "475"
                        "paginaFinal" => "486"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Novel role for &#223;-adrenergic signalling in skeletal muscle growth&#44; development and regeneration"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "J&#46;G&#46; Ryall"
                            1 => "J&#46;E&#46; Church"
                            2 => "G&#46;S&#46; Lynch"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1440-1681.2009.05312.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Exp Pharmacol Physiol&#46;"
                        "fecha" => "2010"
                        "volumen" => "37"
                        "paginaInicial" => "397"
                        "paginaFinal" => "401"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19793099"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:3 [
                  "comentario" => "PMID&#58; 28072631 DOI&#58; 10&#46;1249&#47;MSS&#46;0000000000001199&#46; Pendiente de publicaci&#243;n&#46;"
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Terbutaline Accumulates in Blood and Urine following Daily Therapeutic Inhalation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:7 [
                            0 => "N&#46; Krogh"
                            1 => "S&#46; Rzeppa"
                            2 => "A&#46; Dyreborg"
                            3 => "Y&#46; Dehnes"
                            4 => "P&#46; Hemmersbach"
                            5 => "V&#46; Backer"
                            6 => "M&#46; Hostrup"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1249/mss.0b013e3181453546"
                      "Revista" => array:3 [
                        "tituloSerie" => "Med Sci Sports Exerc&#46;"
                        "fecha" => "2017"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17986905"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/03002896/0000005400000004/v2_201804150418/S0300289617303071/v2_201804150418/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "49741"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Scientific Letters / Cartas cient&#237;ficas"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/03002896/0000005400000004/v2_201804150418/S0300289617303071/v2_201804150418/es/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617303071?idApp=UINPBA00003Z"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Carta científica
La solicitud de autorización de uso terapéutico para agonistas betaadrenérgicos y corticoides inhalados en el deportista con asma
Application for Authorization for Therapeutic Use of Beta-Adrenergic Agonists and Inhaled Corticosteroids in Athletes with Asthma
Franchek Drobnica,b,c,
Corresponding author
drobnic@car.edu

Autor para correspondencia.
, Jesús Blanco-Alfarod
a Departamento de Investigación en Ciencias del deporte del CAR, Sant Cugat del Vallés, Barcelona, España
b Servicios Médicos FC, Barcelona
c Unidad Medicina del Deporte, Hospital San Juan de Dios, Barcelona, España
d Departamento de Control del Dopaje, Agencia Española de Protección de la Salud en el Deporte AEPSAD, Madrid, España
Read
7601
Times
was read the article
2308
Total PDF
5293
Total HTML
Share statistics
 array:24 [
  "pii" => "S0300289617303071"
  "issn" => "03002896"
  "doi" => "10.1016/j.arbres.2017.09.008"
  "estado" => "S300"
  "fechaPublicacion" => "2018-04-01"
  "aid" => "1725"
  "copyright" => "SEPAR"
  "copyrightAnyo" => "2017"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "crp"
  "cita" => "Arch Bronconeumol. 2018;54:223-5"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2133
    "formatos" => array:3 [
      "EPUB" => 133
      "HTML" => 1476
      "PDF" => 524
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S157921291830034X"
      "issn" => "15792129"
      "doi" => "10.1016/j.arbr.2018.02.004"
      "estado" => "S300"
      "fechaPublicacion" => "2018-04-01"
      "aid" => "1725"
      "copyright" => "SEPAR"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "crp"
      "cita" => "Arch Bronconeumol. 2018;54:223-5"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:2 [
        "total" => 1238
        "formatos" => array:3 [
          "EPUB" => 167
          "HTML" => 709
          "PDF" => 362
        ]
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>"
        "titulo" => "Application for Authorization for Therapeutic Use of Beta-Adrenergic Agonists and Inhaled Corticosteroids in Athletes with Asthma"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "223"
            "paginaFinal" => "225"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "La solicitud de autorizaci&#243;n de uso terap&#233;utico para agonistas betaadren&#233;rgicos y corticoides inhalados en el deportista con asma"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Franchek Drobnic, Jes&#250;s Blanco-Alfaro"
            "autores" => array:2 [
              0 => array:2 [
                "nombre" => "Franchek"
                "apellidos" => "Drobnic"
              ]
              1 => array:2 [
                "nombre" => "Jes&#250;s"
                "apellidos" => "Blanco-Alfaro"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "S0300289617303071"
          "doi" => "10.1016/j.arbres.2017.09.008"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617303071?idApp=UINPBA00003Z"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157921291830034X?idApp=UINPBA00003Z"
      "url" => "/15792129/0000005400000004/v2_201804150412/S157921291830034X/v2_201804150412/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0300289617303083"
    "issn" => "03002896"
    "doi" => "10.1016/j.arbres.2017.09.009"
    "estado" => "S300"
    "fechaPublicacion" => "2018-04-01"
    "aid" => "1726"
    "copyright" => "SEPAR"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Arch Bronconeumol. 2018;54:225-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 3220
      "formatos" => array:3 [
        "EPUB" => 124
        "HTML" => 2352
        "PDF" => 744
      ]
    ]
    "es" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Carta cient&#237;fica</span>"
      "titulo" => "Micobacteriosis pulmonar en un paciente en tratamiento cr&#243;nico con metotrexato"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "225"
          "paginaFinal" => "226"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Pulmonary Mycobacteriosis in a Patient Receiving Chronic Methotrexate Treatment"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 563
              "Ancho" => 1400
              "Tamanyo" => 165494
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A&#41; TC tor&#225;cica&#58; consolidaciones pulmonares en l&#243;bulo medio&#44; l&#237;ngula y ambos l&#243;bulos inferiores&#46; B&#41; Biopsia transbronquial basal derecha&#58; presencia de neumonitis granulomatosa no necrosante &#40;tinci&#243;n hematoxilina-eosina&#44;4<span class="elsevierStyleHsp" style=""></span>x&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Mar&#237;a Agustina Dal Mol&#237;n-Veglia, Francisca S&#225;nchez-Mart&#237;nez, Antonio Fernando Fern&#225;ndez-Alarza, Marisol Dom&#237;nguez-&#193;lvarez"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Mar&#237;a Agustina"
              "apellidos" => "Dal Mol&#237;n-Veglia"
            ]
            1 => array:2 [
              "nombre" => "Francisca"
              "apellidos" => "S&#225;nchez-Mart&#237;nez"
            ]
            2 => array:2 [
              "nombre" => "Antonio Fernando"
              "apellidos" => "Fern&#225;ndez-Alarza"
            ]
            3 => array:2 [
              "nombre" => "Marisol"
              "apellidos" => "Dom&#237;nguez-&#193;lvarez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1579212918300351"
        "doi" => "10.1016/j.arbr.2018.02.005"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212918300351?idApp=UINPBA00003Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617303083?idApp=UINPBA00003Z"
    "url" => "/03002896/0000005400000004/v2_201804150418/S0300289617303083/v2_201804150418/es/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S030028961730306X"
    "issn" => "03002896"
    "doi" => "10.1016/j.arbres.2017.08.010"
    "estado" => "S300"
    "fechaPublicacion" => "2018-04-01"
    "aid" => "1724"
    "copyright" => "SEPAR"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Arch Bronconeumol. 2018;54:222-3"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2879
      "formatos" => array:3 [
        "EPUB" => 160
        "HTML" => 2144
        "PDF" => 575
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>"
      "titulo" => "Systemic Lupus Erythematosus Presenting as Acute Lupus Pneumonitis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "222"
          "paginaFinal" => "223"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Lupus eritematoso sist&#233;mico manifestado como neumonitis l&#250;pica aguda"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1179
              "Ancho" => 1250
              "Tamanyo" => 188470
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">66-Year-old woman with systemic lupus erythematosus presenting with acute lupus pneumonitis&#46; &#40;A&#41; Chest X-ray showing right pleural effusion &#40;asterisk&#41; and pulmonary consolidation in right upper lobe&#46; &#40;B&#41; On the chest X-ray three days later&#44; a right encapsulated pleural effusion &#40;asterisk&#41; was observed&#46; &#40;C&#41; Practical disappearance of encapsulated effusion in the thoracic study two months later&#44; with a thickening of the right costal pleura and a lateral costophrenic sinus&#46; &#40;D&#41; Axial section of the computed tomography study at 6 months&#44; at the level of the pulmonary bases with a mediastinum window was normal&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Biljana Lazovic, Mirjana Zlatkovic-Svenda, Damir Jasarovic, Dejan Stevanovic"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Biljana"
              "apellidos" => "Lazovic"
            ]
            1 => array:2 [
              "nombre" => "Mirjana"
              "apellidos" => "Zlatkovic-Svenda"
            ]
            2 => array:2 [
              "nombre" => "Damir"
              "apellidos" => "Jasarovic"
            ]
            3 => array:2 [
              "nombre" => "Dejan"
              "apellidos" => "Stevanovic"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1579212918300533"
        "doi" => "10.1016/j.arbr.2017.08.018"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212918300533?idApp=UINPBA00003Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S030028961730306X?idApp=UINPBA00003Z"
    "url" => "/03002896/0000005400000004/v2_201804150418/S030028961730306X/v2_201804150418/en/main.assets"
  ]
  "es" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Carta cient&#237;fica</span>"
    "titulo" => "La solicitud de autorizaci&#243;n de uso terap&#233;utico para agonistas betaadren&#233;rgicos y corticoides inhalados en el deportista con asma"
    "tieneTextoCompleto" => true
    "saludo" => "<span class="elsevierStyleItalic">Estimado Director&#58;</span>"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "223"
        "paginaFinal" => "225"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Franchek Drobnic, Jes&#250;s Blanco-Alfaro"
        "autores" => array:2 [
          0 => array:4 [
            "nombre" => "Franchek"
            "apellidos" => "Drobnic"
            "email" => array:1 [
              0 => "drobnic&#64;car&#46;edu"
            ]
            "referencia" => array:4 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              3 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Jes&#250;s"
            "apellidos" => "Blanco-Alfaro"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:4 [
          0 => array:3 [
            "entidad" => "Departamento de Investigaci&#243;n en Ciencias del deporte del CAR&#44; Sant Cugat del Vall&#233;s&#44; Barcelona&#44; Espa&#241;a"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Servicios M&#233;dicos FC&#44; Barcelona"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Unidad Medicina del Deporte&#44; Hospital San Juan de Dios&#44; Barcelona&#44; Espa&#241;a"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
          3 => array:3 [
            "entidad" => "Departamento de Control del Dopaje&#44; Agencia Espa&#241;ola de Protecci&#243;n de la Salud en el Deporte AEPSAD&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "d"
            "identificador" => "aff0020"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Application for Authorization for Therapeutic Use of Beta-Adrenergic Agonists and Inhaled Corticosteroids in Athletes with Asthma"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Desde que en 1972 Rick Demont perdiera su medalla de oro en Munich por tomar una medicaci&#243;n no permitida&#44; la legislaci&#243;n antidopaje en el &#225;mbito del asma y el deporte se ha ido adecuando cada temporada para ser m&#225;s concisa y facilitar la vida del deportista con asma y como no&#44; la del m&#233;dico que prescribe la medicaci&#243;n&#46; Desde enero del 2013 se puede tratar el asma sin grandes limitaciones y sin necesidad de elevar una solicitud a organismos deportivos oficiales<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">1&#44;2</span></a>&#46; Pero&#44; hay que leer la normativa&#44; porque la permisividad se fundamenta en una terapia adecuada&#46; En ese sentido&#44; el apartado S3 sobre la normativa reza lo siguiente<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">3</span></a>&#58; <span class="elsevierStyleItalic">&#171;Se proh&#237;ben todos los beta-2 agonistas selectivos y no selectivos&#44; incluidos todos sus is&#243;meros &#243;pticos&#46; Incluidos&#44; entre otros&#58; fenoterol&#59; formoterol&#59; higenamina&#59; indacaterol&#59; olodaterol&#59; procaterol&#59; reproterol&#59; salbutamol&#59; salmeterol&#59; terbatulina&#59; vilanterol&#46; Excepto&#58; salbutamol inhalado&#58; cantidad m&#225;xima 1&#46;600 mcg en 24 h&#44; sin superar los 800 mcg cada 12 h&#46; Formoterol inhalado&#58; dosis m&#225;xima administrada 54 mcg en 24 h&#46; Salmeterol inhalado&#58; cantidad m&#225;xima 200 mcg en 24 h&#46; Que se corresponde a unos rangos de dosis superiores a las terap&#233;uticas de los tres&#46; Se presumir&#225; que la presencia en la orina de una concentraci&#243;n de salbutamol superior a 1&#46;000 nanogramos por mililitro o de formoterol superior a 40 nanogramos por mililitro no corresponde a un uso terap&#233;utico intencionado de la sustancia y se considerar&#225; un resultado anal&#237;tico adverso &#40;AAF&#41;&#44; a menos que el deportista demuestre mediante un estudio farmacocin&#233;tico controlado que este resultado adverso fue consecuencia del uso de la dosis terap&#233;utica &#40;por inhalaci&#243;n&#41; que alcanzaba la dosis m&#225;xima indicada supra&#187;&#46;</span> Es decir&#44; se permite salbutamol&#44; salmeterol y&#47;o formoterol asociado o no a cualquiera de los corticoides inhalados del mercado farmac&#233;utico a dosis terap&#233;uticas&#46; En esos casos no hay que enviar ninguna solicitud&#44; solo dedicarse al paciente&#46; Si se considera que precisa un broncodilatador de los que no est&#225;n permitidos por razones terap&#233;uticas propias de la idiosincrasia personal&#44; de evoluci&#243;n con terapias previas&#44; adherencia&#44; sensaciones o comodidad de uso&#44; etc&#46; se deber&#225; justificar la raz&#243;n de esa decisi&#243;n y aportar la documentaci&#243;n que demuestre que el sujeto es asm&#225;tico y que padece una labilidad bronquial real&#44; mediante una solicitud de autorizaci&#243;n terap&#233;utica &#40;AUT&#41;&#46; En ella se deber&#225; demostrar primero&#44; mediante informes precisos y pruebas cl&#237;nicas avaladas la enfermedad que se padece<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">4</span></a>&#59; segundo&#44; que la sustancia prohibida o m&#233;todo en cuesti&#243;n es necesario para tratar un problema m&#233;dico agudo o cr&#243;nico de tal naturaleza que la salud experimentar&#237;a un deterioro significativo si no fuera tratado&#59; tercero&#44; que no existe una alternativa terap&#233;utica razonable al uso de la sustancia prohibida y cuarto&#44; que es muy improbable que el tratamiento pueda producir una mejora de su rendimiento superior a la que podr&#237;a preverse al regresar a su estado de salud normal<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">5</span></a>&#46; La raz&#243;n de que algunos agonistas beta2 no est&#233;n permitidos no es un capricho o una maniobra econ&#243;mica de grupos de presi&#243;n&#44; se basa en el cuarto punto de las condiciones para solicitar una AUT y es porque estas sustancias a dosis terap&#233;uticas s&#237; tratan el asma&#44; pero en concentraciones elevadas&#44; adem&#225;s&#44; ofrecen un efecto ergog&#233;nico diverso<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">6&#44;7</span></a> que es utilizado con fines anti&#233;ticos por algunos individuos&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">La eficiencia de nuestro trabajo como m&#233;dicos se traslada a la de todos aquellos a quien alcanza&#44; al paciente&#44; a su familia&#44; los organismos deportivos&#44; los compa&#241;eros que nos ayudan a hacer las pruebas complementarias&#44; o los que valoran las solicitudes&#46; Una AUT no es un tr&#225;mite&#46; No basta con rellenar un formulario de solicitud&#46; Es una solicitud oficial&#44; seria&#44; para permitir tomar una medicaci&#243;n y debe ser completa y bien argumentada&#46; En ella&#44; ser&#225; necesario adjuntar pruebas complementarias que afectan a diversos profesionales&#44; en las que los resultados no siempre son los deseados<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">8</span></a>&#44; hay justificar los puntos expuestos que condicionan la solicitud y cumplimentar un documento oficial&#46; En definitiva&#44; hay que dedicar calidad en el trabajo y tiempo&#46; Es tambi&#233;n perentorio matizar que una AUT no es un documento para presentar &#171;por si acaso&#187; y tramitarlo porque se ha o&#237;do que &#171;estas medicaciones pueden dar dopaje&#187;&#46; Las medicaciones para el asma y para otras patolog&#237;as o son dopaje o no lo son&#44; o pueden devenir un control de <span class="elsevierStyleItalic">resultado adverso</span> en unas condiciones determinadas&#46; Cualquier solicitud la eval&#250;a cada uno de los miembros de la Comisi&#243;n de Autorizaciones Terap&#233;uticas de la Agencia Espa&#241;ola Antidopaje y Protecci&#243;n de la Salud del Deportista &#40;CAUT&#41; y genera dedicaci&#243;n de diversas personas a la vez que ciertos tr&#225;mites administrativos&#46; La CAUT no juzga los tratamientos <span class="elsevierStyleItalic">per se</span>&#44; juzga si la solicitud de ese tratamiento&#44; que est&#225; refrendado por un m&#233;dico especialista&#44; cumple los requisitos adecuados para permitir al deportista utilizar una sustancia prohibida que&#44; si bien facilitar&#225; entrenar y competir en condiciones de salud similares a sus compa&#241;eros en una competici&#243;n limpia&#44; tambi&#233;n puede beneficiarle en su rendimiento<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">9</span></a>&#46; Este nivel comentado de calidad no siempre se observa&#46; Como se ve en la tabla adjunta &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#44; de un total de 465 solicitudes realizadas durante el a&#241;o 2015&#44; 131&#40;28&#44;2&#37;&#41; eran de agonistas beta&#44; y de estas 61&#40;46&#44;6&#37;&#41; no proced&#237;a hacerlas&#46; Por otra parte&#44; en una de cada cuatro de las 69 correspondientes a terbutalina&#44; se solicit&#243; la subsanaci&#243;n pidiendo un informe m&#225;s completo&#44; o razonando sobre todo los puntos 2&#46;&#176; y 3&#46;&#176; antes indicados&#46; Abundo en este aspecto pues el tercer punto es el que hay que justificar m&#225;s&#44; pues existe tratamiento alternativo a la misma&#44; y el cuarto es el que impide que algunos broncodilatadores no est&#233;n permitidos y precisen AUT<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">10&#44;11</span></a>&#46; Con respecto al total de las solicitudes de uso de corticoides en relaci&#243;n con el asma&#44; cerca del 100&#37; no son procedentes dado que son tratamientos y v&#237;as de administraci&#243;n permitidas&#46; En resumen&#44; de 202 solicitudes relacionadas con el tratamiento del asma formalizadas por neum&#243;logos&#44; alerg&#243;logos&#44; pediatras&#44; m&#233;dicos de familia&#44; m&#233;dicos generalistas y m&#233;dicos del deporte&#44; 132&#40;65&#37;&#41; no eran necesarias y 21&#40;10&#37;&#41; hubo que repetirlas&#46; Seguro que lo sabemos hacer mejor&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "multimedia" => array:1 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Se indican los porcentajes de las m&#225;s importantes&#46; Las relativas a betametasona y budesonida no son solo para el asma y pertenecen tambi&#233;n a terapias antiinflamatorias de otros sistemas&#46; De las correspondientes a asma no se deneg&#243; ninguna&#46;</p>"
          "tablatextoimagen" => array:2 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " colspan="6" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Autorizaciones terap&#233;uticas resueltas a&#241;o 2015 -n&#58; 465-</th></tr><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Beta2 agonistas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Solicitudes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">No procede&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Subsanaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Concedida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">No concedida o desestimada&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Formoterol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">23&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">23&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Salbutamol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">31&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">31&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Salmeterol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Terbutalina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">69 &#40;52&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">17 &#40;24&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">39 &#40;56&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">13 &#40;18&#44;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Vilanterol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">131&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">61 &#40;46&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">17 &#40;13&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">40 &#40;30&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">13 &#40;9&#44;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1720587.png"
              ]
            ]
            1 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Corticoesteroides&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Solicitudes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">No procede&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Subsanaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Concedida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">No concedida o desestimada&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Prednisona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">36&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">31&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Budesonida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">27&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">24 &#40;88&#44;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Fluticasona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">27&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">26 &#40;96&#44;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Metilprednisolona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">23&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dexametasona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">23&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">21&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Betametasona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">15&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10 &#40;66&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Deflazacort&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">15&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">15&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Triamcinolona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Beclometasona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">7 &#40;87&#44;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Mometasona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ciclesonida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Metilprednisona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Otros&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">192&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">77 &#40;40&#44;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">11 &#40;5&#44;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">103 &#40;53&#44;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">12 &#40;6&#44;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1720586.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Caracter&#237;sticas de las resoluciones de las autorizaciones terap&#233;uticas valoradas por la Comisi&#243;n de Autorizaciones Terap&#233;uticas de la AEPSAD durante el a&#241;o 2015</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:11 [
            0 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "La informaci&#243;n desinformada&#58; el asma en los deportistas de &#233;lite&#46; De Maim&#243;nides a los Juegos Ol&#237;mpicos"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "F&#46; Drobnic"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Bronconeumol&#46;"
                        "fecha" => "2001"
                        "volumen" => "37"
                        "paginaInicial" => "363"
                        "paginaFinal" => "365"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11674933"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "El deportista con asma y la nueva normativa antidopaje de 2010 Menos trabajo a cambio de una terapia limitada"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "F&#46; Drobnic"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.arbres.2009.11.006"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Bronconeumol&#46;"
                        "fecha" => "2010"
                        "volumen" => "46"
                        "paginaInicial" => "280"
                        "paginaFinal" => "281"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20092924"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Bolet&#237;n Oficial del Estado&#44; N&#250;m&#46; 6&#44; S&#225;bado 7 de enero de 2017&#46; Sec&#46; I&#46; pp&#46; 766-775&#46;"
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0120"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "&#91;consultado 16 Oct 2017&#93; &#46; Disponible en&#58; https&#58;&#47;&#47;www&#46;wada-ama&#46;org&#47;en&#47;resources&#47;therapeutic-use-exemption-tue&#47;medical-information-to-support-the-decisions-of-tuecs-asthma&#46;"
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0125"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "&#91;consultado 16 Oct 2017&#93;&#46; Disponible en&#58; http&#58;&#47;&#47;www&#46;aepsad&#46;gob&#46;es&#47;aepsad&#47;control-dopaje&#47;autorizaciones-de-uso-terapeutico&#46;html&#46;"
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Can asthma treatment in sports be doping&#63; The effect of the rapid onset&#44; long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "K&#46;H&#46; Carlsen"
                            1 => "E&#46; Hem"
                            2 => "T&#46; Stensrud"
                            3 => "T&#46; Held"
                            4 => "K&#46; Herland"
                            5 => "P&#46; Mowinckel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/rmed.2001.1105"
                      "Revista" => array:6 [
                        "tituloSerie" => "Respir Med&#46;"
                        "fecha" => "2001"
                        "volumen" => "95"
                        "paginaInicial" => "571"
                        "paginaFinal" => "576"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11453313"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "&#946;-Agonists and physical performance&#58; a systematic review and meta-analysis of randomized controlled trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "B&#46;M&#46; Pluim"
                            1 => "O&#46; de Hon"
                            2 => "J&#46;B&#46; Staal"
                            3 => "J&#46; Limpens"
                            4 => "H&#46; Kuipers"
                            5 => "S&#46;E&#46; Overbeek"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2165/11537540-000000000-00000"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sports Med&#46;"
                        "fecha" => "2011"
                        "volumen" => "41"
                        "paginaInicial" => "39"
                        "paginaFinal" => "57"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21142283"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Consideraciones sobre el informe de la prueba de broncoconstricci&#243;n en el deportistaJT Arch Med Deporte"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "F&#46; Drobnic"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "fecha" => "1997"
                        "volumen" => "58"
                        "paginaInicial" => "147"
                        "paginaFinal" => "148"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mechanisms underlying enhancements in muscle force and power output during maximal cycle ergometer exercise induced by chronic &#40;2-adrenergic stimulation in men"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Hostrup"
                            1 => "A&#46; Kalsen"
                            2 => "J&#46; Onslev"
                            3 => "S&#46; Jessen"
                            4 => "C&#46; Haase"
                            5 => "S&#46; Habib"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Appl Physiol &#40;1985&#41;&#46;"
                        "fecha" => "2015"
                        "volumen" => "119"
                        "paginaInicial" => "475"
                        "paginaFinal" => "486"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Novel role for &#223;-adrenergic signalling in skeletal muscle growth&#44; development and regeneration"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "J&#46;G&#46; Ryall"
                            1 => "J&#46;E&#46; Church"
                            2 => "G&#46;S&#46; Lynch"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1440-1681.2009.05312.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Exp Pharmacol Physiol&#46;"
                        "fecha" => "2010"
                        "volumen" => "37"
                        "paginaInicial" => "397"
                        "paginaFinal" => "401"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19793099"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:3 [
                  "comentario" => "PMID&#58; 28072631 DOI&#58; 10&#46;1249&#47;MSS&#46;0000000000001199&#46; Pendiente de publicaci&#243;n&#46;"
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Terbutaline Accumulates in Blood and Urine following Daily Therapeutic Inhalation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:7 [
                            0 => "N&#46; Krogh"
                            1 => "S&#46; Rzeppa"
                            2 => "A&#46; Dyreborg"
                            3 => "Y&#46; Dehnes"
                            4 => "P&#46; Hemmersbach"
                            5 => "V&#46; Backer"
                            6 => "M&#46; Hostrup"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1249/mss.0b013e3181453546"
                      "Revista" => array:3 [
                        "tituloSerie" => "Med Sci Sports Exerc&#46;"
                        "fecha" => "2017"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17986905"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/03002896/0000005400000004/v2_201804150418/S0300289617303071/v2_201804150418/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "49741"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Scientific Letters / Cartas cient&#237;ficas"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/03002896/0000005400000004/v2_201804150418/S0300289617303071/v2_201804150418/es/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617303071?idApp=UINPBA00003Z"
]
Article information
ISSN: 03002896
Original language: Spanish
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 6 4 10
2024 October 55 23 78
2024 September 71 12 83
2024 August 101 39 140
2024 July 61 26 87
2024 June 128 31 159
2024 May 84 28 112
2024 April 64 22 86
2024 March 87 23 110
2024 February 63 32 95
2023 December 0 5 5
2023 September 0 7 7
2023 August 0 2 2
2023 June 0 1 1
2023 May 0 1 1
2023 April 0 1 1
2023 March 20 6 26
2023 February 106 27 133
2023 January 73 26 99
2022 December 111 42 153
2022 November 183 34 217
2022 October 105 55 160
2022 September 70 37 107
2022 August 78 44 122
2022 July 76 56 132
2022 June 81 33 114
2022 May 114 56 170
2022 April 131 47 178
2022 March 137 44 181
2022 February 105 34 139
2022 January 131 42 173
2021 December 53 57 110
2021 November 80 50 130
2021 October 83 64 147
2021 September 56 47 103
2021 August 43 45 88
2021 July 56 42 98
2021 June 64 63 127
2021 May 91 62 153
2021 April 173 127 300
2021 March 89 49 138
2021 February 91 36 127
2021 January 64 39 103
2020 December 59 32 91
2020 November 65 21 86
2020 October 85 31 116
2020 September 42 28 70
2020 August 54 28 82
2020 July 64 36 100
2020 June 57 16 73
2020 May 76 28 104
2020 April 57 18 75
2020 March 42 10 52
2020 February 95 34 129
2020 January 86 25 111
2019 December 93 26 119
2019 November 122 21 143
2019 October 70 13 83
2019 September 80 24 104
2019 August 52 28 80
2019 July 74 29 103
2019 June 71 12 83
2019 May 74 23 97
2019 April 82 32 114
2019 March 92 30 122
2019 February 57 29 86
2019 January 68 31 99
2018 December 98 50 148
2018 November 119 36 155
2018 October 146 60 206
2018 September 8 6 14
2018 May 2 2 4
2018 April 19 17 36
2018 February 0 2 2
2018 January 0 5 5
2017 December 0 1 1
2017 November 0 3 3
Show all

Follow this link to access the full text of the article

Archivos de Bronconeumología

Are you a health professional able to prescribe or dispense drugs?